On 18 January 2016 the company announced it has agreed to a Long Term Incentive Plan ‘LTIP’ with Mr. John Sharman, the CEO of Medical Developments International Limited to encourage his long term commitment to the business.
The key plan features are summarised as follows:
A grant of 200,000 options with a strike price of $2.50 but vesting only when reimbursement is approved for Penthrox® in Germany or Registration is approved in Germany (whichever occurs first). These options will expire on the 31 December 2016.
Only 7 days to go, Cutting it fine John.
Ann: Annual Report to shareholders-MVP.AX, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
-0.005(1.05%) |
Mkt cap ! $40.56M | |||
| Open | High | Low | Value | Volume |
| 47.5¢ | 48.5¢ | 47.0¢ | $12.31K | 25.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 6111 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 49.0¢ | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |